Abstract
Hereditary factors play a fundamental role in the pathogenesis of breast cancer (BC). Approximately 15–20% of all BCs have been reported to show familial clustering. In spite of the recent demonstration and chromosomal localization of BC predisposing genes, clinical clues and careful inspection of pedigree still remain major instruments in HBC diagnosis. The aim of the present study was to develop minimum operational criteria for the selection of family groups at high risk of developing BC. Following a stepwise procedure, families were stratified into four clusters with increasing probability of genetic involvement. So far, 317 BC‐prone families have been identified and distributed in the four groups, and 151 high risk women underwent our clinical and mammographic surveillance program. Among these, after a mean follow‐up of 24 months, six BCs and one OC were diagnosed (one BC and one OC occurred in the same woman) and one ‘interval’ BC was observed. Since the prevalence rate so far detected is dramatically higher than that seen at the first round of Italian population‐screening programs, our preliminary data support the usefulness of the proposed procedure in selecting high risk individuals.
Similar content being viewed by others
References
Israeli D, Tartter PI, Brower ST, Mizrachy B, Bratton J: The significance of family history for patients with carcinoma of the breast. J Am Coll Surg 179: 29-32, 1994
Lynch HT, Lynch J, Conway T, Watson P, Feunteun J, Lenoir G, Narod 5, Fitgibbons R, Jr.: Hereditary breast cancer and family cancer syndromes. World J Surg 18: 21-31, 1994
Newman B, Austin MA, Lee M, King MC: Inheritance of human breast cancer: Evidence for autosomal dominant transmission in high risk families. Proc Natl Acad Sci USA 85: 3044-3048, 1988
Li FP, Garber JE, Friend FH, Strong LC, Patenaude AF, Juengst ET, Reilly PR, Correa P, Fraumeni JF, Jr.: Recommendations of predictive testing for germ-line p53 mutations among cancer-prone individuals. J Natl Cancer Inst 84: 1156-1160, 1992
Birch JM: The Li-Fraumeni cancer family syndrome. J Pathol 161: 1-2, 1990
Morrell D, Cromartie E, Swift M: Mortality and cancer incidence in 263 patients with AT. JNCI 77: 89-92, 1986
Lynch HT, Guirgis HA, Albert 5, Brennan M, Lynch J, Kraft C, Pocekay D, Vaughns C, Kaplan A: Familial association of carcinoma of the breast and ovary. Surg Gynecol Obstet 138: 717-724, 1974
Lynch HT, Krush AJ, Guirgis H: Genetic factors in families with combined gastrointestinal and breast cancer. Am J Gastroenterol 59: 31-40, 1973
Padberg GW, Schot JD, Vielvoye GJ, Bots GT, de Beer FC: Lhermitte-Duclos disease and Cowden disease: A single phakomatosis. Ann Neurol 29: 517-523, 1991
Lynch HT, Watson P, Conway TA, Lynch JF: Natural history and age at onset of hereditary breast cancer. Cancer 69: 1404-1407, 1992
Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC: Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250: 1684-1689, 1990
Wooster R, Neuhausen S, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D, Fields P, Marshall G, Narod S, Lenoir GM, Lynch H, Feunteun J, Devilee P, Cornelisse CJ, Menko FH, Daly PA, Ormiston W, McManus R, Pye C, Lewis CM, Cannon-Albright LA, Peto J, Ponder BA, Skolnick MH, Easton DF, Goldgar DE, Stratton MR: Localization of a breast susceptibility gene, BRCA2, to chromosome 13q 12–13. Science 265: 2088, 1994
Malkin D, Li FP, Strong LC, Fraumeni JF, Jr., Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science 250: 1233-1238, 1990
Savitsky K, Sfez 5, Tagle DA, Ziv Y, Sartiel A, Collins FS, Shiloh Y, Rotman G: The complete sequence of the coding region of ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet 4: 2025-2032, 1995
Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero, Bonney G, Gold K, Trock B, Main D, Lynch J, Fulmore C, Snyder C, Lemon S, Conway T, Tonin P, Lenoir G, Lynch H: BRCA1 testing in families with hereditary breastovarian cancer: A prospective study of patient decision making and outcomes. JAMA 275: 1885-1892, 1996
Lynch HT, Watson P, Conway T, Fitzimmons ML, Lynch J: Breast cancer family history as a risk factor for early onset breast cancer. Breast Cancer Res Treat 11: 263-267, 1988
Burke W, Daly M, Garber J, Botkin J, Kahn MJE, Lynch P, McTieman A, Offit K, Perlman J, Petersen G, Thomson E, Varricchio C, for the Cancer Genetics Studies Consortium: Recommendations for follow-up care of individuals with an inherited predisposition to cancer. JAMA 277: 997-1008, 1997
Lynch HT, Watson P, Conway TA, Lynch JF: Clinical/genetic features in hereditary breast cancer. Breast Cancer Res Treat 15: 63-71, 1990
Vasen HFA, Mecklin JP, Watson P, Utsunomiya J, Bertario L, Lynch P, Svendsen LB, Cristofaro G, Muller H, Khan PM: Surveillance in HNPCC: An international cooperative study of 165 families. Dis Colon Rectum 36: 1-4, 1993
Zelada-Hedman M, Wasteson Arver B, Claro A, Chen J, Werelius B, Kok H, Sandelin K, Hakansson S, Andersen TI, Borg A, Borresen Dale AL, Lindblom A: A screening for BRCA1 mutations in breast and breast-ovarian cancer families from the Stockholm region. Cancer Res 57: 2474-2477, 1997
Vasen HFA, Mecklin JP, Khan PM, Lynch TH: The International Collaborative Study Group on Hereditary Nonpolyposis Colorectal Cancer. Dis Colon Rectum 34: 424-425, 1991
Claus EB: The calculation of breast cancer risk for women with a first degree family history of ovarian cancer. Cancer 73: 643, 1993
Sattin RW, Rubin GL, Webster LA, Huezo CM, Wingo PA, Ory HW, Layde PM: Family history and risk of breast cancer. JAMA 253: 1908-1913, 1985
Walker RA, Lees E, Webb MB, Dearing SJ: Breast carcinomas occurring in young women (35 years) are different. Br J Cancer 74: 1796-1800, 1996
Otten JD, van Dick JA, Peer PG, Straatman H, Verbeek AL, Mravunac M, Hendrikis JH, Holland R: Long term breast cancer screening in Nijmegen, The Netherlands: The nine rounds from 1975–92. J Epidemiol Commun Health 50: 353-358, 1996
Evans WP III, Starr AL, Bennos S: Comparison of the relative incidence of impalpable invasive breast carcinoma and ductal carcinoma in situ in cancers detected in patients older and younger than 50 years of age. Radiology 204: 489-491, 1997
John V, Ewen K, Kurz E, Teske HJ: Value of different systems of mammography records with regard to their exposure to radiation and their information content. Strahlentherapie 154: 101-106, 1978
Mettler FA, Upton AC, Kelsey CA, Ashby RN, Rosenberg RD, Linver MN: Benefits versus risks from mammography: A critical reassessment. Cancer 77: 903-909, 1996
Vasen HFA, Offerhaus GJA, den Hartog Jager FC, Menko FH, Nagengast FM, Griffioen G, van Hogezand RB, Heintz AP: The tumour spectrum in hereditary non-polyposis colorectal cancer: A study of 24 kindreds in The Netherlands. Int J Cancer 46: 31-34, 1990
Filippini L, Braga M, Perna E, Bianchi AM, Bettoni C, Lucini L, Pezzola D, Pinelli D, Tonini G, Callea F: Results of a mammographic and clinical screening in a health district (USSL) of Brescia, Italy. Tumori 82: 430-436, 1996
Paci E, Ciatto S, Buiatti E, Cecchini S, Palli D, Rosselli del Turco M: Early indicators of efficacy of breast cancer screening programmes: Results of the Florence District Programme. Int J Cancer 46: 198-202, 1990
Elston CW: The assessment of histological differentiation in breast cancer. Aust N Z J Surg 54: 11-15, 1984
Elston CW, Ellis IO: Pathological prognostic factors in breast cancer: I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology 19: 403-410, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Federico, M., Maiorana, A., Mangone, L. et al. Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: the Modena Study Group proposal. Breast Cancer Res Treat 55, 213–221 (1999). https://doi.org/10.1023/A:1006192230332
Issue Date:
DOI: https://doi.org/10.1023/A:1006192230332